Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. - Wikidata - awgldk - TriplyDB

Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.

Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.

http://www.wikidata.org/entity/Q34941521

about

A comparison of different antibiotic regimens for the treatment of infective endocarditis Antibiotic therapy for treatment of infective endocarditis Efficacy and safety of daptomycin for the treatment of infectious disease: a meta-analysis based on randomized controlled trials Gentamicin-induced ototoxicity and nephrotoxicity vary with circadian time of treatment and entail separate mechanisms.Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1).Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.Clinical management of Staphylococcus aureus bacteremia: a review.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the Eu Clinical experience with daptomycin in Europe: the first 2.5 years.Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes Methicillin-resistant Staphylococcus aureus USA300 clone as a cause of Lemierre's syndrome.Multivalvular infective endocarditis in pregnancy presenting with septic pulmonary emboli.Predictors of mortality in Staphylococcus aureus Bacteremia A comparative study for the inactivation of multidrug resistance bacteria using dielectric barrier discharge and nano-second pulsed plasma.Combination therapy for treatment of infections with gram-negative bacteria.Combination therapy with an aminoglycoside for Staphylococcus aureus endocarditis and/or persistent bacteremia is associated with a decreased rate of recurrent bacteremia: a cohort study.Cefazolin and Ertapenem, a Synergistic Combination Used To Clear Persistent Staphylococcus aureus Bacteremia Invasive community-associated MRSA infections: epidemiology and antimicrobial management.The strategy of antibiotic use in critically ill neutropenic patients The efficacy and safety of antibiotic combination therapy for infections caused by Gram-positive and Gram-negative organisms.Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy.Rational use of aminoglycosides--review and recommendations by the Swedish Reference Group for Antibiotics (SRGA).Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk.Aminoglycoside therapy in infectious diseases.Enterococcus faecalis infective endocarditis: focus on clinical aspects.New pharmacological treatments for methicillin-resistant Staphylococcus aureus infections.Vancomycin-associated renal dysfunction: where are we now?The Nephrotoxicity of Vancomycin Raf-kinase inhibitor GW5074 shows antibacterial activity against methicillin-resistant Staphylococcus aureus and potentiates the activity of gentamicin.Use of bacterial whole-genome sequencing to understand and improve the management of invasive Staphylococcus aureus infections.Significant Publications on Infectious Diseases Pharmacotherapy in 2016.No increased risk of acute kidney injury after a single dose of gentamicin in patients with sepsis.Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention.2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the Eur Low-dose Gentamicin for Uncomplicated Enterococcus faecalis Bacteremia May be Nephrotoxic in Children.My paper 10 years later: infective endocarditis in the intensive care unit.Repurposing Zidovudine in combination with Tigecycline for treating carbapenem-resistant Enterobacteriaceae infections.Comparative activities of telavancin combined with nafcillin, imipenem, and gentamicin against Staphylococcus aureus Contemporary drug treatment of infective endocarditis.

P2860

Q24185887-5834C984-0759-45B4-999A-56C6B129BBDC Q24198788-F05608B2-9040-41F2-B0FA-06107DED6A3A Q27000445-3E91952A-B53F-4E6D-9A8A-0E8D5F9F9DDB Q30371562-8D61A999-2FB2-47F1-9BA9-5DF0E4B0146E Q33753500-4EE48B1B-2758-4F62-BEF5-8F84B49076C0 Q34157657-3F69B5D5-E78A-4D6E-A535-7F120116573E Q34441035-743A1D45-759C-4E2D-81AD-DDF9CCA406C1 Q34478074-D4BD0C7C-027E-4044-888B-89873FDBB089 Q34611253-0D703ACC-2C3F-4B86-B58D-1699932C4739 Q34681219-8EDD7D56-98EF-4933-90A4-2DDF040727D1 Q34766191-C6E0DA95-F380-4E54-B706-C921AFEEEFE0 Q35066619-C209F3DB-490F-4C29-89E0-24156D0BD46C Q35614568-169902AC-D948-4EA4-AFE2-9E51AC435B1D Q35940556-63C49778-1BC4-478C-9C47-BD29402AD9F7 Q36039494-D91D6722-DB61-46DA-A329-6D6697D761B4 Q36156077-49D2DDF5-26DD-4456-9FF3-3F1859A43508 Q36409472-839A1CF2-8CF1-4AD7-A7EB-E2BCC59DB8E6 Q37358638-CA607304-4271-4449-A4C9-27AE0C4119E5 Q37800939-903AAA9B-A561-49D2-B4F9-0F73413E5961 Q37929895-07CF7159-80E0-497B-9A36-EA7846C71272 Q37954711-62F41248-8810-4B1B-8A11-3BAF9BA3403D Q37956597-3DA5FF3D-8222-45D4-85D0-3FE04102DA45 Q38070006-985366BA-0FA5-4339-BF74-91475A0BE354 Q38090988-639ACBC0-155C-4689-BFC4-D471A96E7D52 Q38112810-9A3CBB48-EC2B-4755-9559-81D81AE3E64C Q38145269-DC8064F2-0FD1-471F-BFD3-13F93B546DCA Q38179460-A52A76A1-1695-457A-881F-8A7702886896 Q38249103-30D0E68B-BB63-4574-86B1-3C0CD818D107 Q38687487-CA9BD458-DCCC-419D-BC7E-D99A3BCC17C5 Q38819114-88B04121-19E7-4F13-BE43-16F9B06C0599 Q39392178-CBEA786D-D2C9-441A-8DE5-0B99D83CA7C1 Q40067736-B390ABB6-F1F0-44BD-A547-E3C855C2CE82 Q40322197-5436293F-C998-4557-BD12-B3205E61B15A Q40697398-E05E6B8C-8B30-4460-94B0-64CAED966C7B Q41026009-56A8C2DD-F529-40AB-8BD4-D812DCD84343 Q41155969-EACB577A-5EDF-44FD-AB9F-F335D668FE5B Q41732633-1B824744-324F-412C-A9CB-9642B8191928 Q41919457-2E42CD41-15A4-40A0-8171-95EA312D8BA4 Q42090736-2553806A-F81A-418D-B5C7-5F231ACF560A Q42264366-CCB49F85-832A-4C95-9E9A-737DB9AC709E

P2860

Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.

http://www.wikidata.org/entity/Q34941521

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Initial low-dose gentamicin fo ...... d endocarditis is nephrotoxic.

@ast

Initial low-dose gentamicin fo ...... d endocarditis is nephrotoxic.

@en

Initial low-dose gentamicin fo ...... d endocarditis is nephrotoxic.

@nl

type

label

Initial low-dose gentamicin fo ...... d endocarditis is nephrotoxic.

@ast

Initial low-dose gentamicin fo ...... d endocarditis is nephrotoxic.

@en

Initial low-dose gentamicin fo ...... d endocarditis is nephrotoxic.

@nl

prefLabel

Initial low-dose gentamicin fo ...... d endocarditis is nephrotoxic.

@ast

Initial low-dose gentamicin fo ...... d endocarditis is nephrotoxic.

@en

Initial low-dose gentamicin fo ...... d endocarditis is nephrotoxic.

@nl

P1433

Q34941521-2E71D6AD-971C-48DE-B884-6617DD8182D5

P1476

Q34941521-86BEE750-4B64-4784-9C58-E8D28C00AF33

P2093

Q34941521-41FDCEBE-6E12-4366-9DA8-1234FAEBCC47

Q34941521-45D0AA27-95D8-4495-91F0-5F148C19A66E

Q34941521-748E4D60-FB3C-49CA-AD4C-C896844C76EC

Q34941521-796F717B-493A-4CF2-B1DA-E23EAEF47290

Q34941521-7D0DD4C6-5BC8-41B3-B663-97FA65749DF5

Q34941521-93619CFC-AF3F-4BE7-84A8-35DC37016DF2

Q34941521-99F424A9-8918-4446-AE06-2B28B127121E

Q34941521-A0B73C9B-2C19-4EF3-8D42-CB13D9CDCD40

Q34941521-CBE2C769-577A-4685-9CC8-014DFB9CE648

P304

Q34941521-D72D3AF1-F234-4CBE-B01B-0836B845A69F

P31

Q34941521-666C6E55-ADA6-4A6A-ABDD-B46E4C57B955

P356

Q34941521-77F22FED-AE55-4A50-A91E-4E57E64E4E9B

P407

Q34941521-1E8CAA56-289F-4BA5-BAF9-5B6BE0ABE262

P433

Q34941521-50CFA5BF-4A72-4BC8-B108-0F0E3FDEAACF

P478

Q34941521-1C5C046E-1ED9-413A-9F79-840961AC45BA

P50

Q34941521-B7CB2CBC-754F-40ED-A9D2-6449CA5316D9

P577

Q34941521-FBF9265C-762B-49E3-B324-B36CB65C4F00

P5875

Q34941521-AE400FF5-9EA4-445B-9656-268F2094F14A

P698

Q34941521-E415FB7F-C4B0-4CB1-8D0F-F32C4A3A63E9

P921

Q34941521-976D5D4F-A1E5-43F4-8FAA-318D0CEDE077

P356

P1433

Clinical Infectious Diseases

P1476

Initial low-dose gentamicin fo ...... d endocarditis is nephrotoxic.

@en

P2093

Adolf W Karchmer

http://www.w3.org/2001/XMLSchema#string

Donald P Levine

http://www.w3.org/2001/XMLSchema#string

Elias Abrutyn

http://www.w3.org/2001/XMLSchema#string

G Ralph Corey

http://www.w3.org/2001/XMLSchema#string

Gloria A Vigliani

http://www.w3.org/2001/XMLSchema#string

Helen W Boucher

http://www.w3.org/2001/XMLSchema#string

Henry F Chambers

http://www.w3.org/2001/XMLSchema#string

Mark E Rupp

http://www.w3.org/2001/XMLSchema#string

Sara E Cosgrove

http://www.w3.org/2001/XMLSchema#string

P304

713-721

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/597031

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23997629

http://www.w3.org/2001/XMLSchema#string

P698

19207079

http://www.w3.org/2001/XMLSchema#string

P921